We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Stresses Brevity, Relevance in Update to SmPC Guidance
EMA Stresses Brevity, Relevance in Update to SmPC Guidance
February 11, 2013
The European Medicines Agency (EMA) issued additional advice for drugmakers on how to prepare and update a summary of product characteristics (SmPC).
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor